期刊文献+

紫杉醇诱发神经病理性疼痛的治疗研究进展 被引量:5

Research advances in targeted therapy of paclitaxel-induced neuropathic pain
原文传递
导出
摘要 紫杉醇诱发神经病理性疼痛的治疗一直是研究的热点,且其在靶向治疗领域已经取得了一些进展。文章介绍了参与紫杉醇诱发神经病理性疼痛的受体或通路,神经病理性疼痛的特点,紫杉醇诱发神经病理性疼痛的靶向治疗方法的总结以及其他治疗方法的研究进展等内容。通过对紫杉醇诱发神经病理性疼痛的靶向治疗方法的总结,研究和展望未来其他可能的治疗方法,深入探索紫杉醇诱发神经病理性疼痛的有效治疗方法,进一步为临床上的治疗提供可能的依据。 The treatment of paclitaxel-induced neuropathic pain has been a research hotspot.Also,some progress has been made in the field of targeted therapy.In this article,we introduced paclitaxel,summarized the receptors or pathways that involved in pa-clitaxel-induced neuropathic pain,the characteristics of neuropathic pain that induced by paclitaxel,targeted treatment methods of pa-clitaxel-induced neuropathic pain and the progress of other treatment methods.By reviewing the targeted treatment methods of paclitax-el-induced neuropathic pain,we proposed and predicted other possible treatment methods in the future,explored the effective treatment methods of paclitaxel-induced neuropathic pain and provided possible basis for clinical treatment.
作者 缑泽鹏 王秀丽 Gou Zepeng;Wang Xiuli(Department of Anesthesiology,the Third Hospital of Hebei Medical University,Shijiazhuang 050051,China)
出处 《国际麻醉学与复苏杂志》 CAS 2020年第3期305-310,共6页 International Journal of Anesthesiology and Resuscitation
基金 河北省自然科学基金(H2018206260)。
关键词 紫杉醇 神经病理性疼痛 靶向治疗 Paclitaxel Neuropathic pain Targeted therapy
  • 相关文献

参考文献4

二级参考文献27

  • 1邱献华,王海学.新辅助化疗加手术治疗乳腺癌的临床观察[J].现代肿瘤医学,2006,14(9):1071-1073. 被引量:8
  • 2Miln e SE, Troy A, Irwin MG, et al. Relationship between bispectral index, auditory evoked potential index and effect-site EC50 for propofol at two clinical end-points. Br J Anaesth, 2003, 90(2): 127-131.
  • 3Zsigmond EK, Robins G. The effect of a series of anticancer drugs on plasma cholinesterase activity. Can Anaesth Soc J, 1972, 19 (1): 75-82.
  • 4Rajasekhar A, George TJ Jr. Gemcitabine-induced reversible posterior leukoencephalopathy syndrome: a case report and review of the literature. Oncologist, 2007, 12( 11 ) : 1332-1335.
  • 5Martin G, Bellido L, Cruz JJ. Reversible posterior leukoencephalopathy syndrome induced by sunitinib. J Clin Oneol, 2007, 25 (23): 3559.
  • 6Kastrup O, Diener HC. TNF- antagonist etanercept induced reversible posterior leukoencephalopathy syndrome. J Neurol, 2008, 255(3): 452-453.
  • 7Onujiogu N, Lengyel E, Yamada SD. Reversible posterior leukoencephalopathy syndrome following intravenous paclitaxel and intraperitoneal cisplatin chemotherapy for fallopian tube cancer. Gynecol Oncol, 2008, 111(3): 537-539.
  • 8Vardy J, Wefel J, Ahles T, et al. Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop. Ann Oncol, 2008, 19(4): 623-629.
  • 9Muldoon LL, Soussain C, Jahnke K, et al. Chemotherapy delivery issues in central nervous system malignancy: a reality check. J Clin Oncol, 2007, 25(16): 2295-2305.
  • 10Rosenow S, Kooistra KL, Powis G, et al. Increased toxicity of the antitumor drug cyclophosphamide in mice in the presence of the volatile anesthetic agent halothane. Cancer Chemother Pharmacol, 1986, 16(1): 3542.

共引文献99

同被引文献44

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部